These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24774036)

  • 1. High levels of endothelial progenitor cells can be associated with thrombosis in patients with Behçet's disease.
    Bozkirli ED; Keşkek SÖ; Kozanoğlu I; Yücel AE
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S49-53. PubMed ID: 24774036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low levels of endothelial progenitor cells correlate with disease duration and activity in patients with Behçet's disease.
    Fadini GP; Tognon S; Rodriguez L; Boscaro E; Baesso I; Avogaro A; Semenzato G; Agostini C; Marcolongo R
    Clin Exp Rheumatol; 2009; 27(5):814-21. PubMed ID: 19917165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.
    Bozoglu E; Dinc A; Erdem H; Pay S; Simsek I; Kocar IH
    Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S42-8. PubMed ID: 16273763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of soluble E-selectin in patients with active Behcet's disease.
    Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
    Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of endothelial progenitor cells and circulating endothelial cells in patients with Behçet's disease and their relationship to disease activity.
    Arica DA; Akşan B; Örem A; Altinkaynak BA; Yayli S; Sönmez M
    An Bras Dermatol; 2019 Jul; 94(3):320-326. PubMed ID: 31365661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
    Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
    Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evaluation of coagulation parameters and vessel involvement in Behcet' s disease. A clinical experience of Behcet' s disease: study of 152 cases.
    Harman E; Sayarlıoglu M; Harman M; Sayarlıoglu H
    Acta Med Iran; 2013 May; 51(4):215-23. PubMed ID: 23690099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
    Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet's disease.
    Er H; Evereklioglu C; Cumurcu T; Türköz Y; Ozerol E; Sahin K; Doganay S
    Br J Ophthalmol; 2002 Jun; 86(6):653-7. PubMed ID: 12034688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of alpha-1 acid glycoprotein and pentraxin 3 in patients with Behçet's disease and relationship with disease activity.
    Yazmalar L; Batmaz İ; Sula B; Alpaycı M; Aydın F; Türkçü F; Yıldız M; Kaplan İ; Bozkurt M; Dağlı AZ; Burkan YK; Sarıyıldız MA
    Int J Dermatol; 2015 Oct; 54(10):e394-400. PubMed ID: 26147939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Behçet's disease.
    Macey M; Hagi-Pavli E; Stewart J; Wallace GR; Stanford M; Shirlaw P; Fortune F
    Rheumatology (Oxford); 2011 Oct; 50(10):1849-59. PubMed ID: 21719422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
    Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Levels of Circulating Endothelial Progenitor Cells Are Associated with Acrotism in Patients with Takayasu Arteritis.
    Keşkek ŞÖ; Bozkırlı-Ersözlü ED; Kozanoglu I; Yücel AE
    Med Princ Pract; 2017; 26(2):132-138. PubMed ID: 27816980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein.
    Kang SE; Lee SJ; Lee JY; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):67-74. PubMed ID: 28770703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil/lymphocyte ratio and mean platelet volume in Behçet's disease.
    Balkarli A; Kucuk A; Babur H; Erbasan F
    Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3045-50. PubMed ID: 27460734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease?
    Keskin D; Keskin G; Inal A; Ozışık L
    Acta Clin Belg; 2014 Aug; 69(4):246-50. PubMed ID: 25012748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behçet's disease.
    Calis M; Ates F; Yazici C; Kose K; Kirnap M; Demir M; Borlu M; Evereklioglu C
    Rheumatol Int; 2005 Aug; 25(6):452-6. PubMed ID: 15868151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease.
    Buldanlioglu S; Turkmen S; Ayabakan HB; Yenice N; Vardar M; Dogan S; Mercan E
    Br J Dermatol; 2005 Sep; 153(3):526-30. PubMed ID: 16120137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced erythrocyte deformability in active and untreated Behçet's disease patients.
    Tatlican S; Duran FS; Eren C; Eskioglu F; Dikmenoglu N; Oktay B; Durmazlar SP; Canpolat F
    Int J Dermatol; 2010 Feb; 49(2):167-71. PubMed ID: 20465640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.